Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic Malignancies
- 1 March 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Cancer Journal
- Vol. 16 (2), 163-175
- https://doi.org/10.1097/ppo.0b013e3181d7e8cf
Abstract
Radioembolization using radioactive yttrium-90-labeled microspheres is gaining a stronger foothold in the management of primary and metastatic hepatic cancers. The expanding literature reveals good and encouraging results in both retrospective and prospective reports as demonstrated by low acute or late toxicity and high response rates. This treatment modality, which is most beneficial in patients with good liver reserve and low Eastern Cooperative Oncology Group performance status, has led to improved time to liver progression and extended overall patient survival. Although the phase III trials of radioembolization are ongoing as a first-line treatment of patients with metastatic colorectal cancer, there are sufficient phase II and retrospective clinical data supporting its use in salvage therapy for most patients. Patients with hepatocellular cancer, neuroendocrine tumors, and other primary sites, including breast and lung, have also shown promising response and survival increases in multi-institutional experiences.Keywords
This publication has 84 references indexed in Scilit:
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies: Part 1: Technical and Methodologic ConsiderationsJournal of Vascular and Interventional Radiology, 2006
- Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and SurvivalJournal of Vascular and Interventional Radiology, 2005
- Use of yttrium-90 microspheres (TheraSphere®) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case reportLiver Transplantation, 2005
- The Effect of Catheter-Directed CT Angiography on Yttrium-90 Radioembolization Treatment of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2005
- Effects of hepatic arterial yttrium 90 glass microspheres in dogsCancer, 1988
- Intraarterial yttrium 90 in the treatment of hepatic malignancy.Radiology, 1982
- Treatment of patients with advanced cancer utilizing Y90 microspheresCancer, 1965
- Radioactive Isotopes for Adjuvant Cancer TherapyArchives of Surgery, 1964
- Embolization of Dog Prostates With Yttrium-90 MicrospheresJournal of Urology, 1963